Famtozinameran

Records for this ingredient, by country (identity only).

ATC — · 5 markets · 17 records

Famtozinameran 5 markets · 17 records Forms
Filters
MarketAU 6SG 5HK 1
Kind

AU 6 records · 4 shown of 4 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Only this ingredient

  • 50 mcg/mL per mL / per unit basis not statedinjectionCOMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection multidose vialCOMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection single dose vial unknown
  • 17 mcg/mL per mL / per unit basis not statedinjectionCOMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 5/5 micrograms/0.3 mL suspension for injection multidose vialCOMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 5/5 micrograms/0.3 mL suspension for injection single dose vial unknown
  • 0.065 mg per mL / per unit basis not statedinjectionCOMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 5/5 micrograms/0.2 mL concentrated suspension for injection vial unknown
  • 0.02 mg per mL / per unit basis not statedinjectionCOMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 1.5/1.5 micrograms/0.2 mL concentrated suspension for injection vial unknown

SG 5 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 15 mcg/dose per mL / per unit basis not statedinjection CombinationFamtozinameran 15 mcg/dose + Tozinamerán 15 mcg/doseCOMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (MULTI-DOSE VIAL)COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)
  • 5 mcg/dose per mL / per unit basis not statedinjection CombinationFamtozinameran 5 mcg/dose + Tozinamerán 5 mcg/doseCOMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (MDV)COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (SINGLE-DOSE VIAL)
  • 1.5 mcg/dose per mL / per unit basis not statedinjection CombinationFamtozinameran 1.5 mcg/dose + Tozinamerán 1.5 mcg/doseCOMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (15/15 MICROGRAMS)/DOSE ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.